May 7 |
Longboard Pharmaceuticals (NASDAQ:LBPH) Is In A Good Position To Deliver On Growth Plans
|
May 4 |
Longboard Pharmaceuticals Inc. (LBPH) Q1 2024 Earnings: Financial and Strategic Developments
|
May 3 |
Longboard Pharmaceuticals EPS of -$0.42 beats by $0.07
|
May 2 |
Longboard Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Updates
|
May 1 |
Starbucks downgraded, Dollar Tree upgraded: Wall Street's top analyst calls
|
Apr 3 |
Longboard Pharmaceuticals to Present Late-Breaking Data from the PACIFIC Study at the American Academy of Neurology (AAN) Annual Meeting on April 15
|
Mar 27 |
Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) is a favorite amongst institutional investors who own 50%
|
Mar 16 |
Longboard Pharmaceuticals: After Stellar Gains, A Period Of Relative Calm Seems Likely
|
Mar 14 |
Longboard Pharmaceuticals Inc Reports Full Year 2023 Financial Results
|
Mar 12 |
Recap: Longboard Pharmaceuticals Q4 Earnings
|